Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
ADCT on NYSE
Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA
Holdings reported by Redmile Group, LLC for ADC Therapeutics SA
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Shares, par value CHF 0.08 per share |
15.7M |
$44M |
$2.81 |
Jul 1, 2024 |
Indirect |
|
|
Pre-Funded Warrants |
8.16M |
$39.3M |
$4.81 |
May 8, 2024 |
Indirect |
Common Shares |
|
Common Shares, par value CHF 0.08 per share |
13M |
$36.5M |
$2.81 |
Jul 1, 2024 |
Direct |
|
|
Pre-Funded Warrants |
6.11M |
$29.4M |
$4.81 |
May 8, 2024 |
Direct |
Common Shares |
|
Cash-settled Swaps |
108K |
$364K |
$3.38 |
Feb 7, 2024 |
Direct |
Common Shares |
|
Cash-settled Swaps |
11.2K |
$37.8K |
$3.38 |
Feb 2, 2024 |
Indirect |
Common Shares |
|
Transactions reported by Redmile Group, LLC for ADC Therapeutics SA
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.